Wockhardt shares jump 14% after DGCI approves two new antibiotics
Updated : January 16, 2020 01:35 PM IST
Shares of pharma firm Wockhardt surged 14 percent in intra-day deals on Thursday after Indian regulatory DGCA approved its two new antibiotics.
DCGI has approved Wockhardt’s two new antibiotics, EMROK (IV) and EMROK 0 (Oral), for acute bacterial skin and skin structure Infections including diabetic foot infections.
